BioWorld 24. Nov. 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld 24. Nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld 24. Nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III